Draft Scopes of the Risk Evaluations To Be Conducted for Thirteen Chemical Substances Under the Toxic Substances Control Act; Notice of Availability

Published date09 April 2020
Citation85 FR 19941
Record Number2020-07484
SectionNotices
CourtEnvironmental Protection Agency
Federal Register, Volume 85 Issue 69 (Thursday, April 9, 2020)
[Federal Register Volume 85, Number 69 (Thursday, April 9, 2020)]
                [Notices]
                [Pages 19941-19942]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-07484]
                [[Page 19941]]
                =======================================================================
                -----------------------------------------------------------------------
                ENVIRONMENTAL PROTECTION AGENCY
                [EPA-HQ-OPPT-2019-0131; FRL-10007-11]
                Draft Scopes of the Risk Evaluations To Be Conducted for Thirteen
                Chemical Substances Under the Toxic Substances Control Act; Notice of
                Availability
                AGENCY: Environmental Protection Agency (EPA).
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: As required by the Toxic Substances Control Act (TSCA), which
                was amended by the Frank R. Lautenberg Chemical Safety for the 21st
                Century Act in June 2016, EPA is announcing the availability of the
                draft scope documents for the risk evaluations to be conducted for 13
                of 20 High-Priority Substances designated in December 2019. The draft
                scope document for each chemical substance includes the conditions of
                use, hazards, exposures, and the potentially exposed or susceptible
                subpopulations the EPA plans to consider in conducting the risk
                evaluation for that chemical substance. EPA is also opening a 45-
                calendar day comment period on these draft scope documents to allow for
                the public to provide additional data or information that could be
                useful to the Agency in finalizing the scope of the risk evaluations;
                comments may be submitted to this docket and the individual dockets for
                each of the chemical substances.
                DATES: Comments must be received on or before May 26, 2020.
                ADDRESSES: Submit your comments, identified by docket identification
                (ID) number EPA- EPA-HQ-OPPT-2019-0131, or the applicable docket ID
                number for the individual chemical substances identified in Unit III.,
                by one of the following methods:
                 Federal eRulemaking Portal: http://www.regulations.gov.
                Follow the online instructions for submitting comments. Do not submit
                electronically any information you consider to be Confidential Business
                Information (CBI) or other information whose disclosure is restricted
                by statute.
                 Mail: Document Control Office (7407M), Office of Pollution
                Prevention and Toxics (OPPT), Environmental Protection Agency, 1200
                Pennsylvania Ave. NW, Washington, DC 20460-0001.
                 Hand Delivery: To make special arrangements for hand
                delivery or delivery of boxed information, please follow the
                instructions at http://www.epa.gov/dockets/contacts.html.
                 Additional instructions on commenting or visiting the docket, along
                with more information about dockets generally, is available at http://www.epa.gov/dockets.
                FOR FURTHER INFORMATION CONTACT: For technical information contact:
                Ross Geredien, Risk Assessment Division, Office of Pollution Prevention
                and Toxics, Environmental Protection Agency (Mailcode 7403M), 1200
                Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
                (202) 564-1864; email address: [email protected].
                 For general information contact: The TSCA-Hotline, ABVI-Goodwill,
                422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
                554-1404; email address: [email protected].
                SUPPLEMENTARY INFORMATION:
                I. General Information
                A. Does this action apply to me?
                 This action is directed to the public in general and may be of
                interest to entities that manufacture (including import) a chemical
                substance regulated under TSCA (e.g., entities identified under North
                American Industrial Classification System (NAICS) codes 325 and
                324110). The action may also be of interest to chemical processors,
                distributors in commerce, and users; non-governmental organizations in
                the environmental and public health sectors; state and local government
                agencies; and members of the public. Since other entities may also be
                interested, the Agency has not attempted to describe all the specific
                entities and corresponding NAICS codes for entities that may be
                interested in or affected by this action.
                B. What is the Agency's authority for taking this action?
                 This action directly implements TSCA section 6(b)(4)(D), 15 U.S.C.
                2605(b)(4)(D).
                C. What action is the Agency taking?
                 EPA is publishing the draft scopes of the risk evaluations for 13
                of 20 chemical substances designated as High-Priority Substances for
                risk evaluation under TSCA. Through the risk evaluation process, EPA
                will determine whether the chemical substances present an unreasonable
                risk of injury to health or the environment under the conditions of
                use, in accordance with TSCA section 6(b)(4). EPA will publish a second
                Federal Register notice announcing the availability of the draft scope
                documents for the remaining seven chemical substances.
                II. Background
                 TSCA section 6(b)(1) requires EPA to prioritize chemical substances
                for risk evaluation (15 U.S.C. 2605(b)(1)). Effective December 20,
                2019, EPA designated 20 chemical substances as High-Priority Substances
                for risk evaluation (Ref. 1), which initiated the risk evaluation
                process for those chemical substances (15 U.S.C. 2605(b)(3)(A); 40 CFR
                702.17). The purpose of risk evaluation is to determine whether a
                chemical substance presents an unreasonable risk to health or the
                environment, under the conditions of use, including an unreasonable
                risk to a relevant potentially exposed or susceptible subpopulation (15
                U.S.C. 2605(b)(4)(A)). As part of this process, EPA must evaluate both
                hazard and exposure, exclude consideration of costs or other non-risk
                factors, use scientific information and approaches in a manner that is
                consistent with the requirements in TSCA for the best available
                science, and ensure decisions are based on the weight-of-scientific-
                evidence (15 U.S.C. 2605(b)(4)(F)). This process will culminate in a
                determination of whether or not the chemical substance presents an
                unreasonable risk of injury to health or the environment under the
                conditions of use (40 CFR 702.47).
                III. Draft Scopes for 13 of 20 Designated High Priority Chemical
                Substances
                 The 13 chemical substances for which EPA is publishing the draft
                scopes of the risk evaluations are identified in the following Table,
                along with the corresponding Chemical Abstract System Registry Number
                (CASRN) and docket ID numbers.
                 Table--Draft Scopes for 13 of 20 Designated High Priority Chemical Substances
                ----------------------------------------------------------------------------------------------------------------
                 Chemical substance CASRN Docket ID No.
                ----------------------------------------------------------------------------------------------------------------
                1,3-Butadiene.............................. 106-99-0 EPA-HQ-OPPT-2018-0451
                o-Dichlorobenzene (Benzene, 1,2-dichloro-). 95-50-1 EPA-HQ-OPPT-2018-0444
                [[Page 19942]]
                
                p-Dichlorobenzene (Benzene, 1,4-dichloro-). 106-46-7 EPA-HQ-OPPT-2018-0446
                1,1-Dichloroethane......................... 75-34-3 EPA-HQ-OPPT-2018-0426
                1,2-Dichloroethane......................... 107-06-2 EPA-HQ-OPPT-2018-0427
                trans-1,2- Dichloroethylene (Ethene, 1,2- 156-60-5 EPA-HQ-OPPT-2018-0465
                 dichloro-, (1E)-).
                1,2-Dichloropropane........................ 78-87-5 EPA-HQ-OPPT-2018-0428
                Ethylene dibromide (Ethane, 1,2-dibromo-).. 106-93-4 EPA-HQ-OPPT-2018-0488
                1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8- 1222-05-5 EPA-HQ-OPPT-2018-0430
                 hexamethylcyclopenta [g]-2-benzopyran
                 (HHCB).
                4,4'-(1-Methylethylidene)bis[2, 6- 79-94-7 EPA-HQ-OPPT-2018-0462
                 dibromophenol] (TBBPA).
                Phosphoric acid, triphenyl ester (TPP)..... 115-86-6 EPA-HQ-OPPT-2018-0458
                1,1,2-Trichloroethane...................... 79-00-5 EPA-HQ-OPPT-2018-0421
                Tris(2-chloroethyl) phosphate (TCEP) 115-96-8 EPA-HQ-OPPT-2018-0476
                 (Ethanol, 2-chloro-, 1,1',1''-phosphate).
                ----------------------------------------------------------------------------------------------------------------
                 The draft scope of the risk evaluation for each of these 13
                chemical substances includes the conditions of use, hazards, exposures,
                and the potentially exposed or susceptible subpopulations the EPA plans
                to consider. Development of the scope is the first step of a risk
                evaluation. The draft scope of each risk evaluation will include the
                following components (40 CFR 702.41(c)):
                 The conditions of use, as determined by the Administrator,
                that the EPA plans to consider in the risk evaluation.
                 The potentially exposed populations that EPA plans to
                evaluate; the ecological receptors that EPA plans to evaluate; and the
                hazards to health and the environment that EPA plans to evaluate.
                 A description of the reasonably available information and
                the science approaches that the Agency plans to use.
                 A conceptual model that will describe the actual or
                predicted relationships between the chemical substance, the conditions
                of use within the scope of the evaluation and the receptors, either
                human or environmental, with consideration of the life cycle of the
                chemical substance--from manufacturing, processing, distribution in
                commerce, storage, use, to release or disposal--and identification of
                human and ecological health hazards EPA plans to evaluate for the
                exposure scenarios EPA plans to evaluate.
                 An analysis plan, which will identify the approaches and
                methods EPA plans to use to assess exposure, hazards, and risk,
                including associated uncertainty and variability, as well as a strategy
                for using reasonably available information and science approaches.
                 A plan for peer review.
                 With the publication of the draft scopes, EPA is providing a 45-
                calendar day public comment period. Note that, as a result of the Ninth
                Circuit Court of Appeals' decision in Safer Chemicals, Healthy Families
                v. U.S. EPA, 943 F.3d 397, 425 (9th Cir. 2019), EPA will no longer
                exclude legacy uses or associated disposal from the definition of
                ``conditions of use.'' Rather, when these activities are intended,
                known, or reasonably foreseen, these activities will be considered uses
                and disposal, respectively, within the definition of ``conditions of
                use.''
                 EPA encourages commenters to provide information they believe might
                be missing or may further inform the risk evaluation. EPA will publish
                a notice in the Federal Register announcing the availability of the
                final scopes within six months of the initiation of risk evaluations
                that occurred on December 20, 2019 (See Unit IV.).
                IV. References
                 The following is a listing of the documents that are specifically
                referenced in this Federal Register notice. The docket for this action
                includes these documents and other information considered by EPA,
                including documents that are referenced within the documents that are
                included in the docket. For assistance in locating these referenced
                documents, please consult the technical person listed under FOR FURTHER
                INFORMATION CONTACT.
                 EPA. High-Priority Substance Designations Under the Toxic
                Substances Control Act and Initiation of Risk Evaluation on High-
                Priority Substances; Availability. Federal Register. (84 FR 71924,
                December 30, 2019) (FRL-10003-15).
                (Authority: 15 U.S.C. 2601 et seq.)
                Andrew Wheeler,
                Administrator.
                [FR Doc. 2020-07484 Filed 4-8-20; 8:45 am]
                 BILLING CODE 6560-50-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT